Application Nr Approved Date Route Status External Links
NDA022272 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Oxycodone Hcl Extended-Release Tablets Are Indicated For The Management Of Pain Severe Enough To Require Daily, Around-The-Clock, Long-Term Opioid Treatment And For Which Alternative Treatment Options Are Inadequate In: • Adults; And • Opioid-Tolerant Pediatric Patients 11 Years Of Age And Older Who Are Already Receiving And Tolerate A Minimum Daily Opioid Dose Of At Least 20 Mg Oxycodone Orally Or Its Equivalent. Limitations Of Use • Because Of The Risks Of Addiction, Abuse, And Misuse With Opioids, Even At Recommended Doses, And Because Of The Greater Risks Of Overdose And Death With Extended-Release Opioid Formulations [See Warnings And Precautions (5.1)], Reserve Oxycodone Hcl Extended-Release Tablets For Use In Patients For Whom Alternative Treatment Options (E.g., Non-Opioid Analgesics Or Immediate-Release Opioids) Are Ineffective, Not Tolerated, Or Would Be Otherwise Inadequate To Provide Sufficient Management Of Pain. • Oxycodone Hcl Extended-Release Tablets Are Not Indicated As An As-Needed (Prn) Analgesic.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Oxycodone Hydrochloride OXYCODONE HYDROCHLORIDE ZINC403533

Comments